DEXAMETHASONE KRKA 4 mg/ml, solution for injection/for infusion 20 ampoules of 1 ml
Active ingredients: Dexamethasone phosphate, Dexamethasone sodium phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusion20 ampoules of 1 mlinfiltration;intraarticulaire;intralésionnelle;intramusculaire;intraveineuse;sous-conjonctivale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEXAMETHASONE KRKA 4 mg/ml, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- infiltration;intraarticulaire;intralésionnelle;intramusculaire;intraveineuse;sous-conjonctivale
- Presentation description
- 20 ampoule(s) en verre jaune(brun) suremballée(s)/surpochée(s) PVC-Aluminium de 1 mL
- Marketing authorisation holder
- KRKA (SLOVENIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Dec 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62350477CIP73020436CIP133400930204368Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE SODIQUE DE DEXAMÉTHASONEsolution | — | SA |
| PHOSPHATE DE DEXAMÉTHASONEsolution | 4 mg · une ampoule de 1 mL | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.